Cite
HARVARD Citation
Russo, M. et al. (2016). Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism. Clinical endocrinology. pp. 614-619. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Russo, M. et al. (2016). Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism. Clinical endocrinology. pp. 614-619. [Online].